<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17468" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Amniocentesis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jindal</surname>
            <given-names>Aditi</given-names>
          </name>
          <aff>All India Institute Of Medical Sciences</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Medhavi</given-names>
          </name>
          <aff>All India Institute of Medical Sciences, Rajkot, Gujarat, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Karena</surname>
            <given-names>Zalak V.</given-names>
          </name>
          <aff>GMERS Medical College, Morbi</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chaudhary</surname>
            <given-names>Chitra</given-names>
          </name>
          <aff>I.G.M.C. SHIMLA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Aditi Jindal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Medhavi Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zalak Karena declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chitra Chaudhary declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17468.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Amniocentesis is the aspiration of amniotic fluid from the amniotic cavity and is the most common invasive fetal testing procedure. Amniocentesis is an invasive technique. It is usually performed to diagnose or exclude fetal aneuploidy or other fetal genetic, biochemical or infectious risks. Prenatal diagnosis enables the diagnosis of a broad spectrum of chromosomal abnormalities, gene disorders, X-linked conditions, neural tube defects, and infections to be made before the birth of the fetus. The indications grow with progress in these fields. This activity outlines the procedure, reviews its complication rates, describes the complexity of obtaining truly informed consent, and examines the role of the healthcare team in improving care for high-risk patients who undergo this invasive procedure.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the common indications and contraindications of performing amniocentesis.</p></list-item><list-item><p>Describe the equipment required, the technique used, and the patient preparation needed for obtaining valid informed consent and performing an amniocentesis.</p></list-item><list-item><p>Outline and review the possible complications associated with amniocentesis.</p></list-item><list-item><p>Review interprofessional team strategies for obtaining informed consent, care coordination, and communication needed to improve clinical outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17468&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17468">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17468.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Prenatal diagnosis enables the diagnosis of a broad spectrum of chromosomal abnormalities, gene disorders, X-linked conditions, neural tube defects, and infections to be made before the birth of the fetus. The various invasive prenatal diagnostic tests are amniocentesis, chorionic villus sampling, and fetal blood sampling or cordocentesis.</p>
        <p>
<bold>Amniocentesis</bold>
</p>
        <p>Amniocentesis is an invasive technique. This technique removes amniotic fluid from the uterine cavity using a needle. This procedure is performed transabdominally and under ultrasound guidance by a trained obstetrician.&#x000a0;It was first performed for the diagnosis of genetic diseases (sex determination) of the fetus by Fuchs and Riis in 1956.<xref ref-type="bibr" rid="article-17468.r1">[1]</xref>&#x000a0;It is performed for diagnostic and therapeutic purposes, including for diagnostic evaluation in the form of chromosomal, biochemical, histopathological, and microbial assessments. When performed as a therapeutic procedure,&#x000a0;it is done to reduce the volume of amniotic fluid in patients with polyhydramnios.<xref ref-type="bibr" rid="article-17468.r2">[2]</xref><xref ref-type="bibr" rid="article-17468.r3">[3]</xref><xref ref-type="bibr" rid="article-17468.r4">[4]</xref>&#x000a0;</p>
        <p>The amniotic fluid obtained consists of fetal exfoliated cells, transudates, fetal urine, and lung secretions. Amniocentesis can be performed from 15 weeks of gestation to delivery, with an attributable risk of loss in experienced hands of 0.13% in singletons. Earlier the attributable risk is greater than chorion villus sampling&#x000a0;(CVS), which provides similar data from 11 to 15 weeks.&#x000a0;There is an increased risk of amnionic fluid leakage of 1&#x000a0;to 2%, most of which corresponds to decreased activity in days&#x000a0;and fetal demise, which is usually much rarer than the risk of demise attributable to the indication for the procedure, except in low-risk women with no maternal risks indicating the procedure,&#x000a0;and talipes equinovarus, presumably from oligohydramnios.<xref ref-type="bibr" rid="article-17468.r5">[5]</xref></p>
        <p>Counseling of the couple is&#x000a0;necessary regarding the procedure's indications, risks, benefits, and limitations.<xref ref-type="bibr" rid="article-17468.r6">[6]</xref>&#x000a0;This can be complex, as the individual circumstances leading to risk, including maternal age, parental family history, maternal serum screening, sonographic signs of chromosomal and other problems, and population history, can vary significantly. The benefit of possible pregnancy termination also varies depending on the patient's education, religious and ethical preferences, and, at present, state law.&#x000a0;</p>
        <p>
<bold>Chorionic Villus Sampling</bold>
</p>
        <p>It is a prenatal invasive procedure and is done under ultrasound guidance. This procedure uses ultrasonography to guide the catheter or needle into the chorion frondosum. It is done abdominally and is followed by tissue aspiration (chorionic villi) for genetic or chromosomal analysis with a syringe containing tissue culture media. It is done in the first trimester for prenatal diagnosis between 10&#x000a0;to 14 weeks. Depending on the position of the uterus and bladder, the patient's gestational age, and placental localization, it can be performed transabdominally or transcervically.</p>
        <p>The safer and earlier termination of pregnancy is possible as karyotype results are available within 7&#x000a0;to 10 days, although placental mosaicism is a risk for a false diagnosis or reassurance. It is indicated in chromosomal and genetic disorders. The samples collected are sent for DNA analysis. It is not performed in vaginal bleeding, in cases of cervical abnormalities, and severe infections. The major complications involved in this procedure are limb reduction defects from earlier procedures, chromosomal abnormalities present in the extraembryonic tissue, which are not found in the fetal tissue, intrauterine infections, membrane rupture, and fetal loss. The attributable risk in trained hands is similar to amniocentesis. Both procedures assume direct ultrasound guidance for a safe procedure.</p>
        <p>
<bold>Fetal Blood Sampling or Cordocentesis</bold>
</p>
        <p>It is the technique in which, under ultrasound guidance, fetal blood sampling is performed through the maternal abdomen. It is usually performed after 18 weeks after visualization of cord insertion. As the lumen of the cord at earlier weeks of gestation is narrow, it is considered safer to perform at 20&#x000a0;to 28 weeks of gestation. The blood sample is sent to the laboratory for hematological, immunological, and biochemical analysis. The results are obtained within 24&#x000a0;to 72 hours. There is an increased risk of fetal loss, which is comparatively higher (1&#x000a0;to 3% attributable risk) compared with other invasive procedures. The benefits include conversion to fetal transfusion, which can be life-saving. This is commonly indicated in maternal blood group sensitization from a transfusion or prior or current pregnancy sensitization to fetal cells from delivery or miscarriage of fetomaternal hemorrhage, suspected in the case of aplastic anemia from fetal Parvovirus B19 infection with the maternal acquisition of "Slapped face fever"&#x000a0;- more common in teachers, parents, and childcare workers.<xref ref-type="bibr" rid="article-17468.r7">[7]</xref></p>
      </sec>
      <sec id="article-17468.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Amniotic fluid is a transparent fluid&#x000a0;with a light yellowish color. It is present in the amniotic sac. It creates a space for the fetus to grow and survive. It helps permit&#x000a0;fetal movements, which are necessary for the effective musculoskeletal development of the fetus. It helps in fetal swallowing and fetal breathing.</p>
        <p>
<bold>Development </bold>
</p>
        <p>On the 8th day, the trophoblast changes. Bilaminar germ disc formation occurs after the differentiation of embryoblast. On the dorsal aspect of the bilaminar germ disc, there is the presence of tall columnar cells. They are ectodermal in origin.</p>
        <p>On the ventral aspect of the bilaminar germ disc, flattened polyhedral endodermal cells are present. Connecting stalk forms the umbilical cord later; it connects the bilaminar germ disc with the trophoblast.</p>
        <p>There is the appearance of 2 cavities on either side of the germ disc:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Amniotic cavity</p>
          </list-item>
          <list-item>
            <p>Yolk sac</p>
          </list-item>
        </list>
        <p><bold>Physiology of Amniotic Fluid</bold>&#x000a0;</p>
        <p>Maternal and fetal compartments are essential in forming amniotic fluid in the first trimester of pregnancy. Fetal skin is non-keratinized in earlier weeks, allowing free transfer of water and other small molecules and solutes through the amnion and chorionic.<xref ref-type="bibr" rid="article-17468.r8">[8]</xref>&#x000a0;Amniotic fluid is similar to maternal and fetal extracellular fluid and functions as a nonsterile aqueous electrolyte solution.</p>
        <p>During the second trimester of pregnancy, the diffusion process ceases as keratinization of fetal skin occurs, making the fetal skin impervious to water and other solutes.</p>
        <p>On transvaginal ultrasonography, urine is observed at nine weeks in the fetal bladder,&#x000a0;and on transabdominal sonography, urine is seen at 11 weeks of gestation.<xref ref-type="bibr" rid="article-17468.r9">[9]</xref><xref ref-type="bibr" rid="article-17468.r10">[10]</xref>&#x000a0;During this period, the major component of the amniotic fluid is fetal urine. It is hypotonic (80&#x000a0;to 140 mOsm/liter), and as the fetal kidneys mature, they contain increased concentrations of urea, uric acid, and creatinine. At term, a fetus produces 500 to 700 ml of urine per day.<xref ref-type="bibr" rid="article-17468.r11">[11]</xref><xref ref-type="bibr" rid="article-17468.r12">[12]</xref><xref ref-type="bibr" rid="article-17468.r13">[13]</xref></p>
        <p>The average amniotic fluid volume at 12 weeks of gestation is 60 mo.<xref ref-type="bibr" rid="article-17468.r10">[10]</xref>&#x000a0;By 16 weeks, the mean volume is 175 ml.<xref ref-type="bibr" rid="article-17468.r14">[14]</xref>&#x000a0;From 20 weeks on, amniotic fluid volume varies. Amniotic fluid volume increases steadily throughout pregnancy to a maximum of 400&#x000a0;to 1200 ml at 34&#x000a0;to 38 weeks.<xref ref-type="bibr" rid="article-17468.r14">[14]</xref><xref ref-type="bibr" rid="article-17468.r15">[15]</xref><xref ref-type="bibr" rid="article-17468.r16">[16]</xref>&#x000a0;Near term, the net increase of amniotic fluid is only 5&#x000a0;to 10 ml/day in the third trimester. After 38 weeks, fluid volume declines by approximately 125 ml/week to an average volume of 800 ml at 40 weeks.<xref ref-type="bibr" rid="article-17468.r14">[14]</xref><xref ref-type="bibr" rid="article-17468.r15">[15]</xref><xref ref-type="bibr" rid="article-17468.r16">[16]</xref></p>
      </sec>
      <sec id="article-17468.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Amniocentesis is a commonly performed procedure for several reasons. It is performed for:</p>
        <list list-type="order">
          <list-item>
            <p>Diagnostic indications</p>
          </list-item>
          <list-item>
            <p>Therapeutic indications&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Diagnostic Indications</bold>
</p>
        <p>
<bold>Chromosomal Analysis</bold>
</p>
        <p>Karyotyping and DNA analysis (to diagnose sex-linked disorders, inborn errors of metabolism, and neural tube defects).</p>
        <list list-type="bullet">
          <list-item>
            <p>Advanced maternal age (Age &#x0003e; 35years)</p>
          </list-item>
          <list-item>
            <p>Abnormal biochemical screening markers (maternal alpha-fetoprotein, human chorionic gonadotropin, unconjugated estriol) in 1st or 2nd trimester</p>
          </list-item>
          <list-item>
            <p>Ultrasound detection of an abnormality or soft tissue markers (Nuchal translucency, nasal bone hypoplasia, nuchal pad edema, etc.)</p>
          </list-item>
          <list-item>
            <p>Family or personal history of chromosomal abnormalities in previous pregnancies</p>
          </list-item>
          <list-item>
            <p>Abnormal parental karyotype</p>
          </list-item>
          <list-item>
            <p>Parental balanced translocation</p>
          </list-item>
        </list>
        <p>
<bold>Genetic Testing</bold>
</p>
        <p>
<bold>Analysis for Alpha-fetoprotein Level and Acetylcholinesterase&#x000a0;</bold>
</p>
        <p>
<bold>Assessment of Severity of Rh Isoimmunisation</bold>
</p>
        <p>
<bold>Assessment of Bilirubin Levels in Amniotic Fluid and Grade of the Severity of Alloimmunization</bold>
</p>
        <p>Recently non-invasive tests, including the middle cerebral artery Doppler, have gained more importance. It is usually done in the third trimester of pregnancy.</p>
        <p>
<bold>Diagnosis of Fetal Infections</bold>
</p>
        <p>&#x000a0;It can assist in diagnosing TORCH infections.<xref ref-type="bibr" rid="article-17468.r17">[17]</xref>&#x000a0;These include:</p>
        <list list-type="order">
          <list-item>
            <p>CMV</p>
          </list-item>
          <list-item>
            <p>Parvovirus</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Toxoplasma Gondii</italic>
</p>
          </list-item>
        </list>
        <p>
<bold>Fetal Lung Maturation (L/S ratio)</bold>
</p>
        <p>Performed in the third trimester of pregnancy.&#x000a0;</p>
        <p>
<bold>Diagnosis of Chorioamnionitis</bold>
</p>
        <p>
<bold>Diagnosis of Inherited Bleeding Disorders </bold>
</p>
        <p>Such as moderate to severe hemophilia A and B and type 3 von Willebrand disease (VWD) in the third trimester of pregnancy. These disorders have increased fetal risk of&#x000a0;intracranial bleeding during delivery.<xref ref-type="bibr" rid="article-17468.r18">[18]</xref></p>
        <p>
<bold>Therapeutic Indications </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>In hydramnios, it has a therapeutic role in relieving maternal discomfort and the instillation of intraamniotic drugs.</p>
          </list-item>
          <list-item>
            <p>Decompression amniocentesis in twin oligohydramnios-polyhydramnios sequence&#x000a0;(TOPS): as it decreases the volume of amniotic fluid in the polyhydramnios sac, amniotic fluid pressures are decreased in both the sacs resulting in increased placental&#x000a0;thickness thus improving uteroplacental circulation and improving fetal outcome.<xref ref-type="bibr" rid="article-17468.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>It can help in amnioinfusion in oligohydramnios to prevent fetal lung hypoplasia and umbilical cord compression during labor.</p>
          </list-item>
          <list-item>
            <p>It is indicated for fetal blood transfusion in fetuses having severe hemolysis.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17468.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There are no absolute contraindications for amniocentesis.</p>
        <p>Relative contraindications for amniocentesis are:</p>
        <list list-type="order">
          <list-item>
            <p>Hepatitis B and HIV infections can be transmitted from maternal circulation to the fetus during the procedure. It should be deferred in HIV-infected patients until antiretroviral treatment is started and the viral load substantially decreases.&#x000a0;Highly active antiretroviral therapy for HIV greatly reduces maternal to fetal transmission rates.<xref ref-type="bibr" rid="article-17468.r20">[20]</xref><xref ref-type="bibr" rid="article-17468.r21">[21]</xref><xref ref-type="bibr" rid="article-17468.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Decreased amniotic fluid (oligohydramnios)<xref ref-type="bibr" rid="article-17468.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Oral anticoagulation therapy must be stopped 48&#x000a0;to 72 hours before the procedure, and patients may be shifted to low molecular weight heparin.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17468.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The procedure is done under continuous ultrasound guidance. The following equipment is required:</p>
        <list list-type="order">
          <list-item>
            <p>Ultrasonography machine</p>
          </list-item>
          <list-item>
            <p>Sterile swabs and drapes</p>
          </list-item>
          <list-item>
            <p>Syringes: 2 ml, 10 ml</p>
          </list-item>
          <list-item>
            <p>Needle 20 gauge to 22 gauge</p>
          </list-item>
          <list-item>
            <p>Containers for collection and sample transport</p>
          </list-item>
          <list-item>
            <p>5% povidone-iodine solution</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17468.s7" sec-type="Personnel">
        <title>Personnel</title>
        <list list-type="bullet">
          <list-item>
            <p>Couples should undergo genetic counseling.</p>
          </list-item>
          <list-item>
            <p>Informed written consent should be taken.</p>
          </list-item>
          <list-item>
            <p>Risks, benefits, indications, procedures, and complications related to the mother and fetus must be explained in detail to the couple. The fetal and maternal risks associated with the procedure should also be discussed in detail. The time required to obtain results, failure to culture cells, and the type of cytogenetic test performed on the sample should be discussed.</p>
          </list-item>
          <list-item>
            <p>Proper procedure documentation is&#x000a0;necessary, and the number of needle insertion attempts should be recorded.</p>
          </list-item>
          <list-item>
            <p>Ultrasonography before the procedure is done to document the number of fetuses, viability of the fetus, placental location, gestational age, site of cord insertion, and any obvious fetal malformation.</p>
          </list-item>
          <list-item>
            <p>An operator has to have enough experience of at least 20 supervised amniocentesis procedures done under supervision to do this procedure independently. Operators doing amniocentesis in multiple pregnancy situations should be experts in accurate pregnancy mapping, accurate sampling, and selective termination of the pregnancy by correctly identifying the fetus.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17468.s8" sec-type="Preparation">
        <title>Preparation</title>
        <list list-type="order">
          <list-item>
            <p>Both the operator and assistant must scrub with an antiseptic solution and use sterile gloves. The exposed abdominal surface area must be cleaned with povidone-iodine with sterile gauze and antiseptic solutions.</p>
          </list-item>
          <list-item>
            <p>A local anesthetic is not required.</p>
          </list-item>
          <list-item>
            <p>Prophylactic antibiotics are not required.</p>
          </list-item>
          <list-item>
            <p>In Rh-negative women, anti-D immunoglobulin must be administered.<xref ref-type="bibr" rid="article-17468.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>The ultrasound probe must be covered with a sterile plastic cover. The gel must be kept at the inner surface, as it helps better transmit ultrasound waves. Ideally, sterile gel should be used to decrease the risk and spread of contamination.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17468.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Amniocentesis is done as an outpatient procedure. After proper genetic counseling and informed written consent, a detailed ultrasound is performed to assess the gestational age, placental localization, gross congenital anomalies, maximum vertical pocket (MVP) of amniotic fluid, fetal position, fetal movements, fetal cardiac activity, and amniotic fluid volume. Skin is prepared with povidone-iodine, and sterile ultrasonography gel is applied. After confirming the prerequisites and once the preparation is complete, amniocentesis is performed using the aseptic technique. A 20- to 22-gauge spinal needle is used to enter the amniotic cavity under continuous ultrasound guidance. The&#x000a0;entire procedure should be performed in real-time sonographic monitoring with continuous, direct visualization of the spinal needle. The needle is directed to the clear region in the deepest amniotic fluid pocket. Needle insertion in the upper third of the uterus is less painful.<xref ref-type="bibr" rid="article-17468.r25">[25]</xref>&#x000a0;</p>
        <p>The needle, in ideal conditions, is inserted perpendicular to the skin. The transducer is placed in a way that the ultrasound beam is directed at a 15&#x000a0;to 20-degree angle from the planned track of the needle. Figure 1 shows the ultrasound picture of the inserted needle during the amniocentesis procedure. It must be ensured that fetal parts, umbilical cord, or placenta are not present in the region of needle insertion. Transplacental puncture is usually not the preferred point of entry.<xref ref-type="bibr" rid="article-17468.r26">[26]</xref>&#x000a0;Transplacental entry is strictly avoided in cases of alloimmunization or infections to the mother, like human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV).<xref ref-type="bibr" rid="article-17468.r27">[27]</xref><xref ref-type="bibr" rid="article-17468.r28">[28]</xref>&#x000a0;</p>
        <p>A firm entry into the amniotic cavity is recommended to prevent the tenting of the amniotic membrane.<xref ref-type="bibr" rid="article-17468.r29">[29]</xref>&#x000a0;Once entry into the cavity is confirmed, amniotic fluid is slowly aspirated. The initial 1 ml to 2 ml of amniotic fluid is discarded because it has the highest chance of maternal cell contamination.<xref ref-type="bibr" rid="article-17468.r29">[29]</xref>&#x000a0;Approximately 18 ml to 20 ml of amniotic fluid is required for karyotype testing, and 2 ml to 5 ml is required to test for enzyme deficiency testing. The needle is removed after adequate amniotic fluid has been obtained. Fetal wellbeing is confirmed by assessing fetal cardiac activity regularity and fetal movements. This should be witnessed by the patient on ultrasound post-procedure and documented.</p>
        <p>Amniocentesis in twin pregnancies requires the determination of chorionicity and amnionicity. In dichorionic twins, there are two methods:&#x000a0;single-needle technique and two-needle insertion technique. In the single needle technique, after collecting amniotic fluid from one sac, the syringe with the amniotic fluid of the first fetus is removed, and the needle pierces through the septum separating the two amniotic sacs to collect the amniotic fluid from the amniotic sac of the second fetus. This technique has a risk of contamination from the first sac. In the two-needle insertion technique, after collecting amniotic fluid from one sac, a&#x000a0;small amount of blue-colored indigo carmine dye is injected into the sac of the first twin.&#x000a0;Then the needle has pierced the skin and is placed into the sac of the second twin, and fluid is withdrawn. Repeat sampling of blue amniotic fluid allows the operator to know if the amniotic fluid of the first fetus is sampled twice.<xref ref-type="bibr" rid="article-17468.r30">[30]</xref><xref ref-type="bibr" rid="article-17468.r31">[31]</xref></p>
        <p>The patient should be observed after amniocentesis for a short time. She should be instructed to report if there is any vaginal fluid leaking, vaginal bleeding, severe uterine pain, or fever. Routine activities can be resumed after the procedure, but the patient should avoid strenuous exercise.</p>
        <p>Amniocentesis done without ultrasound guidance has 5&#x000a0;to 10 percent failure rates, where no amniotic fluid is aspirated.<xref ref-type="bibr" rid="article-17468.r32">[32]</xref>&#x000a0;Sometimes when amniocentesis is attempted&#x000a0;using a suprapubic needle insertion, there is doubt of the fluid aspirated, be it maternal urine or amniotic fluid. The presence of urea and potassium in maternal urine and&#x000a0;crystalline arborization pattern of dried amniotic fluid in slide observed under magnification confirms the fluid origin.<xref ref-type="bibr" rid="article-17468.r33">[33]</xref><xref ref-type="bibr" rid="article-17468.r34">[34]</xref></p>
      </sec>
      <sec id="article-17468.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Both maternal and fetal complications can occur with amniocentesis.</p>
        <p>
<bold>Maternal Complications </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>There is an estimated 2.6% risk of fetomaternal hemorrhage.</p>
          </list-item>
          <list-item>
            <p>Maternal isoimmunization in Rh-negative cases.</p>
          </list-item>
          <list-item>
            <p>There is minimal chance of introducing skin bacteria into the amniotic cavity. The risk of chorioamnionitis and uterine infections is less than 0.1%.</p>
          </list-item>
          <list-item>
            <p>The procedure increases the risk of preterm labor in the third-trimester amniocentesis. Preterm premature rupture of membrane and oligohydramnios are common complications encountered following amniocentesis.</p>
          </list-item>
          <list-item>
            <p>There is a 2% to 3% risk of vaginal bleeding.</p>
          </list-item>
          <list-item>
            <p>Post-procedure pain and maternal discomfort: Mean pain intensity described is 1.6+/-1.3 when noted on a scale of 0&#x000a0;to 7.<xref ref-type="bibr" rid="article-17468.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Amniotic fluid embolism, very rare</p>
          </list-item>
          <list-item>
            <p>There can be hematoma of maternal skin or intestinal or internal organ injuries.</p>
          </list-item>
        </list>
        <p>
<bold>Fetal Complications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>On average, the fetal loss rate associated with amniocentesis is 0.11%. The loss is 0.56% within 28 days and 0.09% within 42 days.<xref ref-type="bibr" rid="article-17468.r29">[29]</xref>
<list list-type="bullet"><list-item><p>The risk of fetal loss is higher in women who are otherwise at a higher risk of miscarriage, such as women carrying fetuses with structural malformations, fibroids, obese women, and women with vaginal infections at the time of the procedure. Amniocentesis in up to 86.0% of the patients is safe and free from complications.<xref ref-type="bibr" rid="article-17468.r36">[36]</xref>&#x000a0;The risk of fetal loss in case of multiple pregnancies is higher.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Amniotic fluid leak: 1% to 2%, and usually associated with spontaneous sealing of membranes.<xref ref-type="bibr" rid="article-17468.r29">[29]</xref>&#x000a0;It may also result in:
<list list-type="bullet"><list-item><p>Fetal lung hypoplasia</p></list-item><list-item><p>Respiratory distress</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Fetal injuries like bleeding from the cord, ocular injuries, and postural deformities like talipes equinovarus (clubfoot) might occur.
<list list-type="bullet"><list-item><p>The risk of complications is high when more than or equal to 3 pricks are used to obtain amniotic fluid. In ideal conditions, if an adequate fluid sample is not obtained in&#x000a0;two pricks, the procedure should be abandoned for 24 hours,&#x000a0;after which it can be re-attempted. The risk is less in experienced hands, i.e., people who perform more than 300 procedures/year.</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17468.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Amniocentesis procedure is relatively safe, with fewer complications among experienced hands. The location of the placenta is an important factor in amniocentesis. While performing the procedure, one should try to avoid penetration of the placenta. The anterior and fundal placenta is associated with more complications, including multiple pricks and blood-stained liquor; however, it is not associated with increased fetal loss rates.<xref ref-type="bibr" rid="article-17468.r37">[37]</xref>&#x000a0;Passing the needle through the placenta is slightly associated with increased preterm birth rates.<xref ref-type="bibr" rid="article-17468.r38">[38]</xref></p>
        <p>After the amniocentesis procedure, the sample of amniotic fluid is taken to a laboratory for testing. Results usually take ten days to&#x000a0;three weeks depending upon the laboratory. In the laboratory, genetic and chemical tests are done. For genetic tests, specific chromosomes and genes undergo analysis.</p>
        <p>A. For chromosomal and genetic testing, the amniotic fluid is sent for a conventional cell culture report, which is obtained in 14 days. Rapid chromosomal preparations are available that give results in 1 to 2 days, including fluorescent in-situ hybridization (FISH) and quantitative fluorescence polymerase chain reaction (QF-PCR).&#x000a0;</p>
        <p>
<bold>Commonly Performed Tests</bold>
</p>
        <p>1. Rapid test: A rapid test looks for abnormalities on specific chromosomes. This test is almost 100% accurate. A rapid test can identify some chromosomal conditions that cause physical and mental abnormalities. These are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Down's syndrome: caused by extra chromosome 21</p>
          </list-item>
          <list-item>
            <p>Edward's syndrome: caused by extra chromosome 18</p>
          </list-item>
          <list-item>
            <p>Patau's syndrome: caused by an extra chromosome 13</p>
          </list-item>
        </list>
        <p>2. Full karyotype:</p>
        <p>The cells in the sample of amniotic fluid are grown for up to 10 days in a laboratory before being examined under a microscope to check for:</p>
        <list list-type="bullet">
          <list-item>
            <p>Number of chromosomes</p>
          </list-item>
          <list-item>
            <p>Appearance of chromosomes</p>
          </list-item>
        </list>
        <p>Results from a full karyotype will usually be available in two or three weeks. Amniocentesis in the third trimester has higher cell culture failure rates.&#x000a0;</p>
        <p>
<bold>Uncommon Tests</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Chromosomal microarray:&#x000a0;Chromosomal microarray analysis detects a pathogenic copy number variant in approximately 1.7% of patients with a normal karyotype and normal ultrasound examination findings. It can detect chromosomal abnormalities in approximately 6% of the fetuses with normal karyotype and structural abnormalities on ultrasound. Hence, all women opting for invasive prenatal diagnostic testing should be offered chromosomal microarray testing.<xref ref-type="bibr" rid="article-17468.r39">[39]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Molecular amniotic fluid testing helps diagnose single-gene conditions, including X-linked, recessive, and dominant conditions. Parental&#x000a0;mutation should be known preferably before offering prenatal molecular testing for a fetal diagnosis. Ultrasound diagnosis usually indicates molecular testing of a particular condition.<xref ref-type="bibr" rid="article-17468.r40">[40]</xref><xref ref-type="bibr" rid="article-17468.r41">[41]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Various laboratory tests with special testing requirements, such as peroxisomal, biochemical, or methylation conditions, are&#x000a0;useful for diagnosing specific genetic conditions. Methylation study in amniotic fluid helps diagnose fragile X syndrome.<xref ref-type="bibr" rid="article-17468.r42">[42]</xref></p>
          </list-item>
        </list>
        <p>B. Amniotic fluid is analyzed for the presence of proteins, minerals, and other compounds. Amniocentesis results will either be positive or negative. Acetylcholinesterase&#x000a0;(AChE), in conjunction with elevated alpha-fetoprotein (AFP) in amniotic fluid, is considered diagnostic for open neural tube defects.<xref ref-type="bibr" rid="article-17468.r43">[43]</xref>&#x000a0;</p>
        <p>C. Turbid amniotic fluid should be sent for microbiological culture to detect the presence of any organism. Antibiotic coverage should be given to the patient. Occasionally, brown or green amniotic fluid is aspirated during amniocentesis due to intra- amniotic hemorrhage before the amniocentesis procedure due to the breakdown of blood products.<xref ref-type="bibr" rid="article-17468.r44">[44]</xref>&#x000a0;Various studies have shown higher fetal loss rates with the aspiration of such discolored fluid.<xref ref-type="bibr" rid="article-17468.r45">[45]</xref><xref ref-type="bibr" rid="article-17468.r5">[5]</xref></p>
        <p>For most chromosomal conditions, there is no cure, so the couple needs to be appropriately counseled regarding the continuation of pregnancy.</p>
      </sec>
      <sec id="article-17468.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The decision to perform amniocentesis and to convey the results to the couple requires communication between geneticists and fetal medicine experts operating as an interdisciplinary and interprofessional team. Geneticists must counsel the patient&#x000a0;to know the&#x000a0;possibility of the fetus being affected by&#x000a0;a genetic disease. The genetic counselors should educate themselves and verify the availability of the required laboratory testing facilities prior to suggesting a prenatal diagnostic test to the patient. The operator should be aware of the type of samples required to be collected, the type of procedure to be performed, knowledge of the sample collection instrument, sample storage and handling instructions, and prescribed ways&#x000a0;to transport the samples.</p>
        <p>Following the counseling session, the patient is referred for the procedure. While performing the procedure, coordination amongst the team is required. Once the needle is inside the amniotic cavity, the assistant should carefully and promptly withdraw the amniotic fluid so that the procedure is performed in the minimal time possible and with minimal risk of needle displacement. Following the test, the implications of the report should be conveyed to the patient and her family by the geneticists. Consultation with the pediatrician and disability center counselors can be arranged for the patient if required. Meetings with the diagnosed disability social support group and families dealing with a similar disability in a family member help the patient make a proper decision.&#x000a0;</p>
      </sec>
      <sec id="article-17468.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17468&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17468">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17468/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17468">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17468.s14">
        <fig id="article-17468.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Ultrasound picture showing needle insertion during real time sonography guided amniocentesis Contributed by Zalak Karena, MS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_1232" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17468.s15">
        <title>References</title>
        <ref id="article-17468.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eddleman</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Malone</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dukes</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Berkowitz</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Kharbutli</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Luthy</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Comstock</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Saade</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Klugman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dugoff</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Craigo</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Timor-Tritsch</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Wolfe</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>D'Alton</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy loss rates after midtrimester amniocentesis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>108</volume>
            <issue>5</issue>
            <fpage>1067</fpage>
            <page-range>1067-72</page-range>
            <pub-id pub-id-type="pmid">17077226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piantelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bedocchi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cavicchioni</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Verrotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cavallotti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fieni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gramellini</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Amnioreduction for treatment of severe polyhydramnios.</article-title>
            <source>Acta Biomed</source>
            <year>2004</year>
            <volume>75 Suppl 1</volume>
            <fpage>56</fpage>
            <page-range>56-8</page-range>
            <pub-id pub-id-type="pmid">15301292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elliott</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Urig</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Clewell</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Aggressive therapeutic amniocentesis for treatment of twin-twin transfusion syndrome.</article-title>
            <source>Obstet Gynecol</source>
            <year>1991</year>
            <month>Apr</month>
            <volume>77</volume>
            <issue>4</issue>
            <fpage>537</fpage>
            <page-range>537-40</page-range>
            <pub-id pub-id-type="pmid">2002975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nizard</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Amniocentesis: technique and education.</article-title>
            <source>Curr Opin Obstet Gynecol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-4</page-range>
            <pub-id pub-id-type="pmid">20098324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Odibo</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Dicke</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Stamilio</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Macones</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Crane</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience.</article-title>
            <source>Obstet Gynecol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>589</fpage>
            <page-range>589-95</page-range>
            <pub-id pub-id-type="pmid">18310360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinlan</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Amniocentesis: indications and risks.</article-title>
            <source>Virtual Mentor</source>
            <year>2008</year>
            <month>May</month>
            <day>01</day>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>304</fpage>
            <page-range>304-6</page-range>
            <pub-id pub-id-type="pmid">23211983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirchesch</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Infection with parvovirus B19: typical course of erythema infectiosum and its complications].</article-title>
            <source>Z Hautkr</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>65</volume>
            <issue>11</issue>
            <fpage>1007</fpage>
            <page-range>1007-10</page-range>
            <pub-id pub-id-type="pmid">1964320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lind</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hytten</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>The role of the fetus in the formation of amniotic fluid.</article-title>
            <source>J Obstet Gynaecol Br Commonw</source>
            <year>1972</year>
            <month>Apr</month>
            <volume>79</volume>
            <issue>4</issue>
            <fpage>289</fpage>
            <page-range>289-98</page-range>
            <pub-id pub-id-type="pmid">5025135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bronshtein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoffe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brandes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Blumenfeld</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>First and early second-trimester diagnosis of fetal urinary tract anomalies using transvaginal sonography.</article-title>
            <source>Prenat Diagn</source>
            <year>1990</year>
            <month>Oct</month>
            <volume>10</volume>
            <issue>10</issue>
            <fpage>653</fpage>
            <page-range>653-66</page-range>
            <pub-id pub-id-type="pmid">2274490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abramovich</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Fetal factors influencing the volume and composition of liquor amnii.</article-title>
            <source>J Obstet Gynaecol Br Commonw</source>
            <year>1970</year>
            <month>Oct</month>
            <volume>77</volume>
            <issue>10</issue>
            <fpage>865</fpage>
            <page-range>865-77</page-range>
            <pub-id pub-id-type="pmid">4919671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abramovich</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Garden</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jandial</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Fetal swallowing and voiding in relation to hydramnios.</article-title>
            <source>Obstet Gynecol</source>
            <year>1979</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-20</page-range>
            <pub-id pub-id-type="pmid">377164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Otterlo</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Wladimiroff</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Wallenburg</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Relationship between fetal urine production and amniotic fluid volume in normal pregnancy and pregnancy complicated by diabetes.</article-title>
            <source>Br J Obstet Gynaecol</source>
            <year>1977</year>
            <month>Mar</month>
            <volume>84</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-9</page-range>
            <pub-id pub-id-type="pmid">843496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wladimiroff</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Fetal urine-production rates in normal and complicated pregnancy.</article-title>
            <source>Lancet</source>
            <year>1974</year>
            <month>Feb</month>
            <day>02</day>
            <volume>1</volume>
            <issue>7849</issue>
            <fpage>151</fpage>
            <page-range>151-4</page-range>
            <pub-id pub-id-type="pmid">4129720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brace</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Normal amniotic fluid volume changes throughout pregnancy.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1989</year>
            <month>Aug</month>
            <volume>161</volume>
            <issue>2</issue>
            <fpage>382</fpage>
            <page-range>382-8</page-range>
            <pub-id pub-id-type="pmid">2764058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ELLIOTT</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>INMAN</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Volume of liquor amnii in normal and abnormal pregnancy.</article-title>
            <source>Lancet</source>
            <year>1961</year>
            <month>Oct</month>
            <day>14</day>
            <volume>2</volume>
            <issue>7207</issue>
            <fpage>835</fpage>
            <page-range>835-40</page-range>
            <pub-id pub-id-type="pmid">13889956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Queenan</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Whitfield</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SI</given-names>
              </name>
            </person-group>
            <article-title>Amniotic fluid volumes in normal pregnancies.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1972</year>
            <month>Sep</month>
            <day>01</day>
            <volume>114</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-8</page-range>
            <pub-id pub-id-type="pmid">4637037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <collab>American College of Obstetricians and Gynecologists</collab>
            <article-title>ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>110</volume>
            <issue>6</issue>
            <fpage>1459</fpage>
            <page-range>1459-67</page-range>
            <pub-id pub-id-type="pmid">18055749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cutler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chappell</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Kyle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Madan</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Third trimester amniocentesis for diagnosis of inherited bleeding disorders prior to delivery.</article-title>
            <source>Haemophilia</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>904</fpage>
            <page-range>904-7</page-range>
            <pub-id pub-id-type="pmid">23919291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruner</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Crean</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Equalization of amniotic fluid volumes after decompression amniocentesis for treatment of the twin oligohydramnios-polyhydramnios sequence.</article-title>
            <source>Fetal Diagn Ther</source>
            <year>1999</year>
            <season>Mar-Apr</season>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>80</fpage>
            <page-range>80-5</page-range>
            <pub-id pub-id-type="pmid">10085504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Floridia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Masuelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Meloni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cetin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tamburrini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cavaliere</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Dalzero</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sansone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alberico</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Spinillo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chiad&#x000f2; Fiorio Tin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ravizza</surname>
                <given-names>M</given-names>
              </name>
              <collab>Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy</collab>
            </person-group>
            <article-title>Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series.</article-title>
            <source>BJOG</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>124</volume>
            <issue>8</issue>
            <fpage>1218</fpage>
            <page-range>1218-1223</page-range>
            <pub-id pub-id-type="pmid">27319948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ekoukou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Khuong-Josses</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ghibaudo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mechali</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rotten</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Amniocentesis in pregnant HIV-infected patients. Absence of mother-to-child viral transmission in a series of selected patients.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>140</volume>
            <issue>2</issue>
            <fpage>212</fpage>
            <page-range>212-7</page-range>
            <pub-id pub-id-type="pmid">18584937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sim&#x000f5;es</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marques</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Correia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Castela</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guerreiro</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Amniocentesis in HIV pregnant women: 16 years of experience.</article-title>
            <source>Infect Dis Obstet Gynecol</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>914272</fpage>
            <pub-id pub-id-type="pmid">23970821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dubil</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Magann</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Amniotic fluid as a vital sign for fetal wellbeing.</article-title>
            <source>Australas J Ultrasound Med</source>
            <year>2013</year>
            <month>May</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>62</fpage>
            <page-range>62-70</page-range>
            <pub-id pub-id-type="pmid">28191176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wysowski</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Flynt</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Connell</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Rh hemolytic disease. Epidemiologic surveillance in the United States, 1968 to 1975.</article-title>
            <source>JAMA</source>
            <year>1979</year>
            <month>Sep</month>
            <day>28</day>
            <volume>242</volume>
            <issue>13</issue>
            <fpage>1376</fpage>
            <page-range>1376-9</page-range>
            <pub-id pub-id-type="pmid">113567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lekskul</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tannirandorn</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The location of needle insertion effect on maternal pain in amniocentesis.</article-title>
            <source>J Med Assoc Thai</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>89 Suppl 4</volume>
            <fpage>S137</fpage>
            <page-range>S137-41</page-range>
            <pub-id pub-id-type="pmid">17725150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tabor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Philip</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Madsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Obel</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>N&#x000f8;rgaard-Pedersen</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Needle size and risk of miscarriage after amniocentesis.</article-title>
            <source>Lancet</source>
            <year>1988</year>
            <month>Jan</month>
            <day>23</day>
            <volume>1</volume>
            <issue>8578</issue>
            <fpage>183</fpage>
            <page-range>183-4</page-range>
            <pub-id pub-id-type="pmid">2893021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coll</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations.</article-title>
            <source>Fetal Diagn Ther</source>
            <year>2010</year>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-8</page-range>
            <pub-id pub-id-type="pmid">20558971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davies</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>D&#x000e9;silets</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Summers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wyatt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>D</given-names>
              </name>
              <collab>Society of Obstetricians and Gynaecologists of Canada</collab>
            </person-group>
            <article-title>RETIRED: Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-48, 149-52</page-range>
            <pub-id pub-id-type="pmid">12577132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sotiriadis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Calda</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Da Silva Costa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Raine-Fenning</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Alfirevic</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>McGillivray</surname>
                <given-names>G</given-names>
              </name>
              <collab>International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)</collab>
            </person-group>
            <article-title>ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>256</fpage>
            <page-range>256-68</page-range>
            <pub-id pub-id-type="pmid">27485589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vink</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wapner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>D'Alton</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Prenatal diagnosis in twin gestations.</article-title>
            <source>Semin Perinatol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>169</fpage>
            <page-range>169-74</page-range>
            <pub-id pub-id-type="pmid">22713497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weisz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rodeck</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Invasive diagnostic procedures in twin pregnancies.</article-title>
            <source>Prenat Diagn</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>25</volume>
            <issue>9</issue>
            <fpage>751</fpage>
            <page-range>751-8</page-range>
            <pub-id pub-id-type="pmid">16170858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simpson</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Dallaire</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Siminovich</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hamerton</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McKeen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Prenatal diagnosis of genetic disease in Canada: report of a collaborative study.</article-title>
            <source>Can Med Assoc J</source>
            <year>1976</year>
            <month>Oct</month>
            <day>23</day>
            <volume>115</volume>
            <issue>8</issue>
            <fpage>739</fpage>
            <page-range>739-48</page-range>
            <pub-id pub-id-type="pmid">61796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guibaud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bonnet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dury</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thoulon</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dumont</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Letter: Amniotic fluid or maternal urine?</article-title>
            <source>Lancet</source>
            <year>1976</year>
            <month>Apr</month>
            <day>03</day>
            <volume>1</volume>
            <issue>7962</issue>
            <fpage>746</fpage>
            <pub-id pub-id-type="pmid">56559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elias</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Gerbie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Analysis for amniotic fluid crystallization in second-trimester amniocentesis.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1979</year>
            <month>Feb</month>
            <day>15</day>
            <volume>133</volume>
            <issue>4</issue>
            <fpage>401</fpage>
            <page-range>401-4</page-range>
            <pub-id pub-id-type="pmid">434004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Monga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wicklund</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Robbins-Furman</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Strecker</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Mastrobattista</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Clinical correlates of pain with amniocentesis.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>191</volume>
            <issue>2</issue>
            <fpage>542</fpage>
            <page-range>542-5</page-range>
            <pub-id pub-id-type="pmid">15343234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jummaat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mohamed Ismail</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>5-Year review on amniocentesis and its maternal fetal complications.</article-title>
            <source>Horm Mol Biol Clin Investig</source>
            <year>2019</year>
            <month>Sep</month>
            <day>20</day>
            <volume>40</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">31539354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalogiannidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Prapa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dagklis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Karkanaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petousis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prapas</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Prapas</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Amniocentesis-related adverse outcomes according to placental location and risk factors for fetal loss after midtrimester amniocentesis.</article-title>
            <source>Clin Exp Obstet Gynecol</source>
            <year>2011</year>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>239</fpage>
            <page-range>239-42</page-range>
            <pub-id pub-id-type="pmid">21995155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaksuwat</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wanapirak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Piyamongkol</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sirichotiyakul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tongprasert</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Srisupundit</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Luewan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Traisrisilp</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jatavan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tongsong</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A comparison of pregnancy outcomes after second-trimester amniocentesis between cases with penetration of the placenta and nonpenetration.</article-title>
            <source>J Matern Fetal Neonatal Med</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>23</issue>
            <fpage>3883</fpage>
            <page-range>3883-3888</page-range>
            <pub-id pub-id-type="pmid">32299277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <article-title>Practice Bulletin No. 162 Summary: Prenatal Diagnostic Testing for Genetic Disorders.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>May</month>
            <volume>127</volume>
            <issue>5</issue>
            <fpage>976</fpage>
            <page-range>976-978</page-range>
            <pub-id pub-id-type="pmid">27101119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisenberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wapner</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical proceduress in prenatal diagnosis.</article-title>
            <source>Best Pract Res Clin Obstet Gynaecol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>611</fpage>
            <page-range>611-27</page-range>
            <pub-id pub-id-type="pmid">12475543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>South</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Brothman</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Genomic medicine in prenatal diagnosis.</article-title>
            <source>Clin Obstet Gynecol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-73</page-range>
            <pub-id pub-id-type="pmid">18303500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McConkie-Rosell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Finucane</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cronister</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Pettersen</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.</article-title>
            <source>J Genet Couns</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>249</fpage>
            <page-range>249-70</page-range>
            <pub-id pub-id-type="pmid">16047089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheschier</surname>
                <given-names>N</given-names>
              </name>
              <collab>ACOG Committee on Practice Bulletins-Obstetrics</collab>
            </person-group>
            <article-title>ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001).</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <page-range>123-33</page-range>
            <pub-id pub-id-type="pmid">14626221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hankins</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Rowe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Quirk</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Trubey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Strickland</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis.</article-title>
            <source>Obstet Gynecol</source>
            <year>1984</year>
            <month>Sep</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>353</fpage>
            <page-range>353-8</page-range>
            <pub-id pub-id-type="pmid">6205335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17468.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruikshank</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Varner</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Cruikshank</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Donnelly</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Midtrimester amniocentesis. An analysis of 923 cases with neonatal follow-up.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1983</year>
            <month>May</month>
            <day>15</day>
            <volume>146</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-11</page-range>
            <pub-id pub-id-type="pmid">6189400</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
